List of 2024 Presenting Companies
Aegle Therapeutics Corporation
Shelley Hartman, CEO
MA, USA (Private)
Cell Therapy, Inflammation, Orphan/Rare Disease
Mon, Oct 28 at 3:00pm, 12th floor,
Room 12-B
AiM Medical Robotics
Gregory Fischer, PhD, Founder & CEO
MA, USA (Private/TechBio)
Drug Delivery, Neurology, Oncology
Tues, Oct 29 at 11:30am, 12th floor,
Room 12-A
AtlasXomics Inc.
Kenneth Wang, CEO
CT, USA (Private/TechBio)
Bioinformatics, Drug Discovery, Epigenetics
Mon, Oct 28 at 2:45pm, 12th floor,
Room 12-A
AvantGuard Inc
Ted Eveleth, CEO
NY, USA (Private)
Dermatology, Infectious Disease, Platform Technology
Tues, Oct 29 at 2:45pm, 12th floor,
Room 12-A
AyuVis Research, Inc.
Mariam Morris, CFO
TX, USA (Private)
Immunology, Orphan/Rare Disease, Platform Technology
Tues, Oct 29 at 2:15pm, 12th floor,
Room 12-A
BioCurie
Irene Rombel, PhD, CEO, President & Co-Founder
DE, USA (Seed/TechBio)
Artificial Intelligence (AI), Biomanufacturing, Cell & Gene Therapy
Wed, Oct 30 at 10:50am, 12th floor,
Room 12-C
Biotech Therapeutics, LLC
John Barchilon, MD, CEO
FL, USA (Private)
Cell Therapy, CNS/Neurological, Regenerative Medicine
Mon, Oct 28 at 4:00pm, 12th floor,
Room 12-A
BioXtek LLC
Bruce Werber, CEO
FL, USA (Private)
Cardiovascular, Fibrosis, Inflammation
Tues, Oct 29 at 3:00pm, 12th floor,
Room 12-A
BlinkLab Limited
Henk-Jan Boele, MD, PhD, CEO
Australia (Public ASX: BB1)
Diagnostics, Machine Learning, Neurology
Tues, Oct 29 at 2:00pm, 12th floor,
Room 12-B
Bostal LLC
Ron Liu, CEO
NJ, USA (Private)
Cardiovascular, CNS/Neurological, Psychiatric
Wed, Oct 30 at 10:30am, 12th floor,
Room 12-B
Boston Immune Technologies and Therapeutics, Inc.
Russell LaMontagne, CEO
MA, USA (Private)
Antibodies, Autoimmune, Immuno-oncology
Mon, Oct 28 at 4:15pm, 12th floor,
Room 12-A
CARLA Biotherapeutics
Zaki Sellam, PhD, Co-Founder & President
France (Seed)
Cell Therapy, Oncology, Personalized Medicine
Mon, Oct 28 at 2:50pm, 12th floor,
Room 12-C
CellFE Inc.
Alla Zamarayeva, PhD, CEO
CA, USA (Private)
Biomanufacturing, Cell Therapy, Immuno-oncology
Wed, Oct 30 at 10:45am, 12th floor,
Room 12-B
Chimeron Bio
Kevin Heyeck, CEO
PA, USA (Private)
Immuno-oncology, Oncology Combination Therapy, Platform Technology
Tues, Oct 29 at 3:15pm, 12th floor,
Room 12-A
Cytonus Therapeutics
Remo Moomiaie-Qajar, MD, CEO
CA, USA (Private)
Biomanufacturing, Cell Therapy, Drug Delivery
Tues, Oct 29 at 3:00pm, 12th floor,
Room 12-C
Excelsior Sciences
Michael Foley, PhD, CEO
NY, USA (Private/TechBio)
Big Data, Drug Discovery, Machine Learning
Tues, Oct 29 at 3:15pm, 12th floor,
Room 12-B
FlyteHealth
Gabe Castaneda, Chief Revenue Officer
CT, USA (Private)
Cardiovascular, Endocrine/Metabolic, Personalized Medicine
Mon, Oct 28 at 4:15pm, 12th floor,
Room 12-B
Glucotrack Inc.
Paul Goode, CEO
NJ, USA (Public/TechBio NASDAQ: GCTK)
Diagnostics, Endocrine/Metabolic, Neuropathy/Pain
Tues, Oct 29 at 11:00am, 12th floor,
Room 12-B
Helex, Inc.
Poulami Chaudhuri, CEO & Co-Founder
NY, USA (Private)
CRISPR, Platform Technology, Renal
Tues, Oct 29 at 3:15pm, 12th floor,
Room 12-C
Helfie AI
George Tomeski, CEO
Australia (Private)
Artificial Intelligence (AI), Natural language processing (NLP)/Large language models (LLM), Personalized Medicine
Wed, Oct 30 at 10:00am, 12th floor,
Room 12-B
Hervolution Therapeutics
Robert Coleman, CEO
Denmark (Private/TechBio)
CNS/Neurological, Immuno-oncology, Longevity/Healthspan/Diseases of Aging
Mon, Oct 28 at 3:15pm, 12th floor,
Room 12-A
Iaso Biotherapeutics
Alan Fu, PhD, CFO
China (Private)
Antibodies, Autoimmune, Cell Therapy
Tues, Oct 29 at 11:15am, 12th floor,
Room 12-C
iBio, Inc.
Martin Brenner, DVM, PhD, CEO & CSO
CA, USA (Public/TechBio NYSE: IBIO)
Antibodies, Artificial Intelligence (AI), Drug Discovery
Tues, Oct 29 at 11:30am, 12th floor,
Room 12-B
Ideal Medical Technologies Inc.
Leon DeJournett, MD, CEO
NC, USA (Private/TechBio)
Drug Delivery, Endocrine/Metabolic, Machine Learning
Mon, Oct 28 at 3:30pm, 12th floor,
Room 12-A
Illudent Therapeutics
Mark Benedyk, PhD, Senior Advisor
CA, USA (Private)
Drug Discovery, Oncology, Personalized Medicine
Wed, Oct 30 at 10:45am, 12th floor,
Room 12-A
ImBiome Inc.
Peter Michels, PhD, Co-Founder, CEO & CSO
NY, USA (Seed)
Drug Delivery, Microbiome, Platform Technology
Mon, Oct 28 at 4:10pm, 12th floor,
Room 12-C
Immunis, Inc.
Hans Keirstead, Chairman of the Board
CA, USA (Private)
Endocrine/Metabolic, Musculoskeletal, Regenerative Medicine
Mon, Oct 28 at 2:45pm, 12th floor,
Room 12-B
Indaptus Therapeutics, Inc.
Jeffrey Meckler, CEO
NY, USA (Public NASDAQ: INDP)
Immunology, Immuno-oncology, Oncology Combination Therapy
Mon, Oct 28 at 3:30pm, 12th floor,
Room 12-B
Invenis Biotherapies
Boris Molle, PhD, CEO
France (Seed)
CNS/Neurological, Orphan/Rare Disease, Regenerative Medicine
Mon, Oct 28 at 3:00pm, 12th floor,
Room 12-C
Kadence Bio
Ryan Protzko, PhD, President
United Kingdom (Private)
CNS/Neurological, Psychiatric
Mon, Oct 28 at 4:00pm, 12th floor,
Room 12-B
Kaida BioPharma
Craig Pierson, Chairman
FL, USA (Seed)
Other
Mon, Oct 28 at 11:20am, 12th floor,
Room 12-C
Kaleidoscope.bio
Bogdan Knezevic, Co-Founder & CEO
NY, USA (Private/TechBio)
Drug Discovery, Platform Technology, Research Tools
Mon, Oct 28 at 3:00pm, 12th floor,
Room 12-A
Kalm Therapeutics
Chris Seibert, CEO
AL, USA (Seed)
Dermatology, Immunology, Microbiome
Mon, Oct 28 at 3:10pm, 12th floor,
Room 12-C
Lift Biosciences
Antonin de Fougerolles, PhD, Chairman
United Kingdom (Private)
Cell Therapy, Immuno-oncology, Platform Technology
Tues, Oct 29 at 3:00pm, 12th floor,
Room 12-B
Lisata Therapeutics, Inc.
David Mazzo, President & CEO
NJ, USA (Public NASDAQ: LSTA)
Drug Delivery, Oncology, Oncology Combination Therapy
Mon, Oct 28 at 11:00am, 12th floor,
Room 12-A
Lyric Bio, Inc.
Melanie Matheu, PhD, CSO
CA, USA (Seed/TechBio)
Antibodies, Biomanufacturing, Immunology
Mon, Oct 28 at 4:00pm, 12th floor,
Room 12-C
MedGene Therapeutics, Inc.
Yong Park, MD, CEO
MD, USA (Seed)
Cell Therapy, Gene Therapy, Oncology
Mon, Oct 28 at 3:20pm, 12th floor,
Room 12-C
Merlin Biotech, Inc.
Randall Hyer, MD, PhD, CEO
PA, USA (Seed)
Immuno-oncology, Oncology, Platform Technology
Mon, Oct 28 at 3:30pm, 12th floor,
Room 12-C
Molecular You
Gene Shkolnikov, CTO
WA, USA (Private)
Bioinformatics, Longevity/Healthspan/Diseases of Aging, Personalized Medicine
Tues, Oct 29 at 2:30pm, 12th floor,
Room 12-A
Museum of Medicine and Biomedical Discovery
Mace Rothenberg, MD, President & Executive Director
TN, USA (Seed)
Drug Discovery, Longevity/Healthspan/Diseases of Aging, Personalized Medicine
Mon, Oct 28 at 3:40pm, 12th floor,
Room 12-C
Myracle Therapeutics, Inc.
Dawn Bell, PharmD, Executive Chair
NJ, USA (Seed)
Drug Discovery, Endocrine/Metabolic, Longevity/Healthspan/Diseases of Aging
Wed, Oct 30 at 10:10am, 12th floor,
Room 12-C
Myria Biosciences AG
Irene Wüthrich, COO
Switzerland (Seed)
Artificial Intelligence (AI), Drug Discovery, Platform Technology
Mon, Oct 28 at 3:50pm, 12th floor,
Room 12-C
New England Hemolytics Inc.
John Nobile, Founder & CEO
CT, USA (Seed)
Diagnostics, Infectious Disease
Wed, Oct 30 at 10:00am, 12th floor,
Room 12-C
Nostopharma
Ekaterina Vert-Wong, CEO
MD, USA (Seed)
Drug Delivery, Longevity/Healthspan/Diseases of Aging, Musculoskeletal
Mon, Oct 28 at 11:10am, 12th floor,
Room 12-C
NUP-CTx Inc.
Kai Blau, PhD, Business Director
FL, USA (Private)
Oncology Combination Therapy
Tues, Oct 29 at 2:15pm, 12th floor,
Room 12-C
Nusano
Rohan Jain, Chief Commercial Officer
CA, USA (Private/TechBio)
Oncology, Platform Technology, Radiopharmaceuticals
Tues, Oct 29 at 11:00am, 12th floor,
Room 12-A
Octozi
Amit Patel, CEO
NY USA (Seed)
Artificial Intelligence (AI), Big Data, Machine Learning
Wed, Oct 30 at 10:20am, 12th floor,
Room 12-C
Opus Genetics
George Magrath, MD, CEO
MI, USA (Public NASDAQ: OCUP)
Ophthalmic
Wed, Oct 30 at 10:00am, 12th floor,
Room 12-A
Oqory, Inc.
Michael King, CEO
CA, USA (Seed/TechBio)
Antibodies, Oncology, Oncology Combination Therapy
Wed, Oct 30 at 10:40am, 12th floor,
Room 12-C
Origami Therapeutics, Inc.
Beth Hoffman, CEO
CA, USA (Private)
CNS/Neurological, Longevity/Healthspan/Diseases of Aging, Orphan/Rare Disease
Tues, Oct 29 at 11:30am, 12th floor,
Room 12-C
Osmol Therapeutics, Inc.
Bob Linke, President & CEO
CT, USA (Private)
Neurology, Neuropathy/Pain, Oncology
Tues, Oct 29 at 11:00am, 12th floor,
Room 12-C
OYE Therapeutics, Inc.
Brett Dines, CEO & Founder
IN, USA (Private)
CNS/Neurological, Platform Technology, Pulmonary
Tues, Oct 29 at 2:30pm, 12th floor,
Room 12-C
Paint Therapeutics
Bill Reddick, CEO
GA, USA (Seed)
Drug Delivery, Oncology, Pulmonary
Wed, Oct 30 at 10:30am, 12th floor,
Room 12-C
Pictura Bio Ltd
Alex Batchelor, CEO
Oxford, UK & CA, USA (Private/TechBio)
Diagnostics, Infectious Disease, Machine Learning
Tues, Oct 29 at 11:15am, 12th floor,
Room 12-A
Polaris Quantum Biotech, Ltd
Shahar Keinan, PhD, CEO
NC, USA (Private/TechBio)
Drug Discovery, Platform Technology, Quantum Computing
Mon, Oct 28 at 11:00am, 12th floor,
Room 12-B
Port Therapeutics
João Siffert, MD, MBA, CEO
CA, USA (Private)
Cell Therapy, Gene Therapy, Oncology
Mon, Oct 28 at 3:15pm, 12th floor,
Room 12-B
Portrai
Hyung-Jun Im, MD, PhD, CSO
South Korea (Private)
Antibodies, Bioinformatics, Radiopharmaceuticals
Mon, Oct 28 at 11:15am, 12th floor,
Room 12-B
ReSync Bio, Inc.
Mihir Trivedi, CEO
CA, USA (Seed/TechBio)
Contract Drug Development, Drug Discovery, Machine Learning
Mon, Oct 28 at 11:00am, 12th floor,
Room 12-C
Rx Bandz
Jessica Walsh, Founder & CEO
NJ, USA (Private/TechBio)
Drug Delivery, Drug Discovery, Platform Technology
Tues, Oct 29 at 2:00pm, 12th floor,
Room 12-A
Talus Bio
Alex Federation, PhD, Co-Founder & CEO
WA, USA (Private/TechBio)
Artificial Intelligence (AI), Drug Discovery, Proteomics
Tues, Oct 29 at 11:45am, 12th floor,
Room 12-A
Thrive Bioscience, Inc.
Thomas Forest Farb-Horch, CEO & President
MA, USA (Private)
Drug Discovery, Machine Learning, Regenerative Medicine
Wed, Oct 30 at 10:15am, 12th floor,
Room 12-B
Tivic Health Systems, Inc.
Jennifer Ernst, CEO
CA, USA (Public/TechBio NASDAQ:TIVC)
Autoimmune, Neurology, Other
Tues, Oct 29 at 2:30pm, 12th floor,
Room 12-B
Valley Fever Solutions, Inc.
David Larwood, PhD, CEO
AZ, USA (Private)
Artificial Intelligence (AI), Infectious Disease, Orphan/Rare Disease
Tues, Oct 29 at 11:45am, 12th floor,
Room 12-C
VSPharmTech
Hoyun Nam, Director
South Korea (Private)
Oncology, Oncology Combination Therapy
Tues, Oct 29 at 2:45pm, 12th floor,
Room 12-C
XCMR Inc.
Richard Rasansky, CEO
PA, USA (Private/TechBio)
Infectious Disease, Pulmonary
Mon, Oct 28 at 3:45pm, 12th floor,
Room 12-A
XYone Therapeutics Inc
Anshu Goyal, CEO
MA, USA (Private)
Antibodies, Oncology
Wed, Oct 30 at 10:30am, 12th floor,
Room 12-A
Ziphius
Hanne Noyen, Scientific Liaison Manager
NY, USA (Private)
Gene Therapy, Infectious Disease, Platform Technology
Tues, Oct 29 at 2:00pm, 12th floor,
Room 12-C